PSVT Without the Panic: Structured Care That Works
Multiple dates available
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Jörg Latus, MD
Sayna Norouzi, MD
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
Turning the Double Play – Comprehensive Secondary Prevention
Matthew Malachowski, Pharm. D., MHA
Small Ball Wins Games – Combination Therapy for Goal Attainment
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Richard Lafayette, MD, FACP
Ankana Daga, MD
Safety in oHCM Therapy: How and When to Transition Treatment?
Anjali Owens, MD
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
Michael Nassif, MD, MSc
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Ahmad Masri, MD, MS
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Advancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
Roxana Mehran, MD, FSCAI
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Elevating CKD-aP Care: New Frontier